Note that these TSC2 gene mutations have not been detected as frequently as multiple endocrine neoplasia type 1 (MEN1) and death domain-associated protein/alpha thalassemia/mental retardation syndrome X-linked (DAXX/ATRX) gene mutations [20]. This evidence concerns the gene TSC2 and alpha thalassemia spectrum.